首頁 > 市場調查報告書 > 醫療設備

導管

再灌注治療市場：依治療類型、按損傷類型、按分銷管道、按地區：規模、份額、前景、機會分析，2023-2030

市場調查報告書

商品編碼

1350237

再灌注治療市場：依治療類型、按損傷類型、按分銷管道、按地區：規模、份額、前景、機會分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年08月16日 | 出版商:

Coherent Market Insights | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2023 年，全球再灌注治療市場價值將達到 15.467 億美元，預測期內（2023-2030 年）複合年增長率為 4.7%。

報告範圍		報告詳情
基準年	2022年	2023年市場規模	美國：15.467億美元
之前的數據	2018年至2021年	預測期	2023-2030
預測 2023-2030 年複合年增長率：	4.70%	2030年價值預測	21.358 億美元

再灌注療法用於恢復心臟病發作後阻塞動脈的血流。再灌注損傷通常因器官移植或其他損傷而發生。患者接受抗血小板治療、開放性或血管內再灌注治療、冠狀動脈成形術。再灌注傷害可發生在心臟、腎臟、肝臟、腸、肺和腦部等器官。治療再灌注傷害藥物的臨床試驗正在進行中。當血液供應不足導致組織損傷時，就會發生再灌注傷害。中風後的腦損傷是再灌注傷害的一個例子。再灌注治療導致血液流入組織，因發炎和氧化壓力造成氧化損傷。低溫治療、硫化氫療法、環孢菌素和幹細胞療法用於治療再灌注傷害。當再灌注治療延遲時會發生氧化損傷。

市場動態

新產品的推出以及主要市場參與者不斷增加的併購預計將推動全球再灌注治療市場的成長。例如，2021 年 10 月 15 日，針對教育得主的廣泛平台 Study.com 發表了一篇文章，描述了向身體組織供應含氧血液的過程（稱為灌注）。為了了解灌注何時發生，醫生必須先定義一些與心動週期相關的術語。一次心跳有兩個週期。第一個週期稱為 "潤滑" 或收縮期，發生在心室收縮並將血液泵入動脈時。第二個週期，也稱為“dub”或舒張期，是心室放鬆並充滿血液的時候。

本研究的主要特點

本報告詳細分析了全球再灌注治療市場，並提供了以2022年為基準年的預測期（2023-2030）的市場規模和複合年增長率（CAGR）。
它還闡明了不同細分市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
它還提供了有關市場驅動因素、限制因素、機會、新產品發布和批准、市場趨勢、區域前景、主要參與者採取的競爭策略等的重要見解。
它根據公司亮點、產品組合、主要亮點、財務表現和策略等參數，介紹了全球再灌注治療市場的主要參與者。
本研究涵蓋的主要公司包括 Corline Biomedical AB、SBI Holdings Inc.、Pharming Group NV、Mallinckrodt Pharmaceuticals、MIFCOR, Inc.、CFM Pharma Holding BV、Balmes Transplantation SAS、Revive Therapeutics Ltd、Faraday Pharmaceuticals、Radikal Therapeutics Inc、Akalas 、 com, Inc、Angion Biomedica Corp、Young Therapeutics, LLC、Ischemix、Stealth Biotherapeutics Inc 和Bolder Bio Technology Inc.
該報告的見解使行銷人員和公司高管能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球再灌注治療市場報告針對該行業的各個利益相關者，如投資者、供應商、產品製造商、分銷商、新進入者和財務分析師。
利害關係人將透過用於分析全球再灌注治療市場的各種策略矩陣來促進決策。

Corline Biomedical AB
SBI Holdings Inc.
Pharming Group NV
Mallinckrodt Pharmaceuticals
MIFCOR, Inc.
CFM Pharma Holding B.V
Balmes Transplantation SAS
Revive Therapeutics Ltd
Faraday Pharmaceuticals
Radikal Therapeutics Inc
Amyndas Pharmaceuticals, com, Inc.
Angion Biomedica Corp
Young Therapeutics, LLC
Ischemix
Stealth Biotherapeutics Inc
Bolder Bio Technology Inc

第10章

調查方法
關於出版商

簡介目錄

Product Code: CMI4248

The global reperfusion treatment market is estimated to be valued at US$ 1,546.7 Million in 2023 and is expected to exhibit a CAGR of 4.7% during the forecast period (2023-2030).

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 1,546.7 Mn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.70%	2030 Value Projection:	US$ 2,135.8 Mn

Reperfusion therapy is used to restore blood flow in blocked arteries after a heart attack. Reperfusion injury usually occurs as a result of organ transplantation and other injuries. Patients are treated with antiplatelet therapy, open or endovascular revascularization, coronary angioplasty, and others. Reperfusion injury can occur in organs such as the heart, kidneys, liver, intestines, lungs, and brain. Clinical trials are being conducted with drugs designed to treat reflux injuries. Damage to the tissue as a result of a lack of blood supply leads to reperfusion injuries. Brain damage following a stroke is one example of a reperfusion injuries. Reperfusion therapy causes blood to flow into the tissue thatcauses inflammation and oxidative damage from oxidative stress. Therapeutic hypothermia, hydrogen sulfide therapy, cyclosporins, stem cell therapy, and other methods can all be used to treat reperfusion injury. Oxidative damage happens when reperfusion therapy is delayed.

Market Dynamics

Increasing launches of new products and mergers and acquisitions by key market players are expected to drive the global reperfusion treatment market growth. For instance, on October 15, 2021, Study.com, the extensive platform for education gainers, published an article explaining the process of delivering oxygenated blood to the body's tissues known as perfusion. Physicians must first define a few terms related to the heart beat cycle in order to comprehend when perfusion occurs. Two cycles make up one heartbeat. The first cycle, referred to as the "lub," or systole, occurs when the chambers constrict and drive blood into the arteries. The second cycle, also known as the "dub" or diastole, is when the chambers relax and blood fills them.

Key features of the study:

This report provides an in-depth analysis of the global reperfusion treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global reperfusion treatment market based on the following parameters-company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Corline Biomedical AB, SBI Holdings Inc., Pharming Group NV, Mallinckrodt Pharmaceuticals, MIFCOR, Inc., CFM Pharma Holding B.V, Balmes Transplantation SAS, Revive Therapeutics Ltd, Faraday Pharmaceuticals, Radikal Therapeutics Inc, Amyndas Pharmaceuticals, com, Inc, Angion Biomedica Corp, Young Therapeutics, LLC, Ischemix, Stealth Biotherapeutics Inc, and Bolder Bio Technology Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global reperfusion treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global reperfusion treatment market

Detailed Segmentation:

Global Reperfusion Treatment Market, By Treatment Type:
- Therapeutic Hypothermia
- Cyclosporin
- Stem Cell Therapy
- Hydrogen Sulphide Treatment
- Others
Global Reperfusion Treatment Market, By Injury Type:
- Heart Injury
- Kidney Injury
- Intestine Injury
- Others
Global Reperfusion Treatment Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Global Reperfusion Treatment Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
- Corline Biomedical AB
- SBI Holdings Inc.
- Pharming Group NV
- Mallinckrodt Pharmaceuticals
- MIFCOR, Inc.
- CFM Pharma Holding B.V
- Balmes Transplantation SAS
- Revive Therapeutics Ltd
- Faraday Pharmaceuticals
- Radikal Therapeutics Inc
- Amyndas Pharmaceuticals, com, Inc.
- Angion Biomedica Corp
- Young Therapeutics, LLC
- Ischemix
- Stealth Biotherapeutics Inc
- Bolder Bio Technology Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Injury Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Therapeutic Hypothermia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Cyclosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Stem Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Hydrogen Sulphide Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Heart Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Kidney Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Intestine Injury
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Injury Type, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Corline Biomedical AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
SBI Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Pharming Group NV
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Mallinckrodt Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
MIFCOR, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CFM Pharma Holding B.V
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Balmes Transplantation SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Revive Therapeutics Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Faraday Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Radikal Therapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Amyndas Pharmaceuticals, com, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Angion Biomedica Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Young Therapeutics, LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Ischemix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Stealth Biotherapeutics Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Bolder Bio Technology Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/價格

FAQ

再灌注治療市場：依治療類型、按損傷類型、按分銷管道、按地區：規模、份額、前景、機會分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

本研究的主要特點

目錄

第一章研究目的與前提

第二章市場概況

第三章市場動態、法規與趨勢分析

第四章全球再灌注治療市場 - COVID-19 影響分析

第五章全球再灌注治療市場：依治療類型，2018-2030

第六章全球再灌注治療市場：依損傷類型，2018-2030

第七章全球再灌注治療市場：依通路劃分，2018-2030

第八章全球再灌注治療市場：依地區劃分，2018-2030

第9章競爭格局

第10章

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

9. Competitive Landscape

10. Section

再灌注治療市場：依治療類型、按損傷類型、按分銷管道、按地區：規模、份額、前景、機會分析，2023-2030

Reperfusion Treatment Market, By Treatment Type, By Injury Type, By Distribution Channel, and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

本研究的主要特點

目錄

第一章 研究目的與前提

第二章 市場概況

第三章 市場動態、法規與趨勢分析

第四章全球再灌注治療市場 - COVID-19 影響分析

第五章全球再灌注治療市場：依治療類型，2018-2030

第六章全球再灌注治療市場：依損傷類型，2018-2030

第七章全球再灌注治療市場：依通路劃分，2018-2030

第八章全球再灌注治療市場：依地區劃分，2018-2030

第9章 競爭格局

第10章

Key features of the study:

Detailed Segmentation:

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Reperfusion Treatment Market- COVID-19 Impact Analysis

5. Global Reperfusion Treatment Market, By Treatment Type, 2018-2030, (US$ Million)

6. Global Reperfusion Treatment Market, By Injury Type, 2018-2030, (US$ Million)

7. Global Reperfusion Treatment Market, By Distribution Channel, 2018-2030, (US$ Million)

8. Global Reperfusion Treatment Market, By Region, 2018-2030, (US$ Million)

9. Competitive Landscape

10. Section

第一章研究目的與前提

第二章市場概況

第三章市場動態、法規與趨勢分析

第9章競爭格局